Rheumatology News

The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, including those under rheumatology umbrella.

Biomarkers in blood and plasma can be used to predict rheumatoid arthritis-associated interstitial lung disease more accurately than clinical risk factors alone, suggesting potential new opportunities in screening and treatment, data show.

The FDA has approved the Janus kinase inhibitor upadacitinib for the treatment of giant cell arteritis in adults, the first such approval in the disease since tocilizumab received the green light in 2017, according to a press release.

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlighted recent coverage of the rise in physician union membership, as well as Congress’s latest stopgap funding measure.

Mortality risk among patients with Sjögren’s disease is elevated as much as 70% vs. the general population, primarily due to infections and driven by heart and lung involvement, according to data published in The Journal of Rheumatology.

Union membership among health care professionals in the United States, including physicians, is on the rise, which could have seismic implications in work patterns and patient care in an increasingly corporatized medical system.

In rheumatology, there is always more to learn — even when it comes to the most well-trod topics and commonly researched conditions.

Health savings accounts are a powerful tool for managing health care expenses, offering significant tax advantages and flexibility.

In the final part of this series, Joseph Parambil, MD, walks us through the approach of managing pulmonary hypertension, reviews the pathophysiology and digs into the mechanisms and the differences in the medications.